Biolase Price to Book Ratio 2006-2021 | BIOL

Historical price to book ratio values for Biolase (BIOL) over the last 10 years. The current price to book ratio for Biolase as of July 30, 2021 is 2.57.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Biolase Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-07-30 0.57 2.55
2021-03-31 0.84 $0.22 3.76
2020-12-31 0.42 $0.10 4.06
2020-09-30 0.28 $0.15 1.85
2020-06-30 0.46 $0.03 17.81
2020-03-31 0.38 $-0.03 -13.25
2019-12-31 0.55 $0.14 4.00
2019-09-30 0.94 $-0.05 -19.34
2019-06-30 1.47 $0.17 8.48
2019-03-31 2.38 $0.33 7.27
2018-12-31 0.99 $0.50 1.96
2018-09-30 2.07 $0.79 2.62
2018-06-30 1.21 $0.99 1.22
2018-03-31 2.03 $1.22 1.67
2017-12-31 2.13 $1.43 1.49
2017-09-30 3.01 $1.39 2.17
2017-06-30 4.85 $1.67 2.91
2017-03-31 6.75 $1.36 4.97
2016-12-31 7.00 $1.63 4.29
2016-09-30 8.75 $1.93 4.54
2016-06-30 5.85 $1.63 3.60
2016-03-31 6.55 $1.85 3.53
2015-12-31 4.21 $2.14 1.96
2015-09-30 4.50 $2.26 1.99
2015-06-30 8.70 $2.67 3.26
2015-03-31 10.10 $3.19 3.16
2014-12-31 13.15 $3.62 3.63
2014-09-30 12.45 $1.26 9.86
2014-06-30 11.00 $0.39 28.52
2014-03-31 12.05 $1.20 10.07
2013-12-31 14.08 $1.20 11.74
2013-09-30 9.47 $1.35 7.01
2013-06-30 17.63 $1.26 14.03
2013-03-31 19.51 $1.50 12.96
2012-12-31 9.02 $1.89 4.79
2012-09-30 8.25 $1.61 5.13
2012-06-30 9.42 $1.65 5.71
2012-03-31 13.02 $1.86 7.01
2011-12-31 12.29 $2.02 6.09
2011-09-30 14.20 $2.23 6.36
2011-06-30 24.09 $2.34 10.29
2011-03-31 22.60 $0.73 30.81
2010-12-31 8.04 $-0.59 -13.58
2010-09-30 5.38 $-0.66 -8.10
2010-06-30 6.94 $-0.25 -28.30
2010-03-31 8.96 $0.51 17.45
2009-12-31 8.77 $1.51 5.81
2009-09-30 10.38 $1.72 6.02
2009-06-30 7.76 $1.47 5.29
2009-03-31 4.11 $0.92 4.46
2008-12-31 6.85 $1.78 3.85
2008-09-30 8.68 $2.74 3.16
2008-06-30 15.71 $3.53 4.45
2008-03-31 14.20 $3.30 4.30
2007-12-31 10.84 $3.16 3.43
2007-09-30 31.42 $3.49 9.01
2007-06-30 27.89 $4.00 6.97
2007-03-31 44.70 $4.01 11.15
2006-12-31 40.20 $4.24 9.47
2006-09-30 28.71 $4.08 7.04
2006-06-30 38.59 $3.86 10.00
2006-03-31 43.87 $3.91 11.23
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.086B $0.023B
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $74.377B 20.09
Align Technology (ALGN) United States $55.064B 79.25
McKesson (MCK) United States $32.243B 11.84
West Pharmaceutical Services (WST) United States $30.396B 58.82
Laboratory Of America Holdings (LH) United States $28.934B 8.74
Straumann Holding AG (SAUHF) Switzerland $28.671B 0.00
AmerisourceBergen (ABC) United States $25.095B 14.46
Cooper (COO) United States $20.771B 35.18
Cardinal Health (CAH) United States $17.229B 10.20
DENTSPLY SIRONA (XRAY) United States $14.418B 31.75
Henry Schein (HSIC) United States $11.277B 24.51
STAAR Surgical (STAA) United States $5.999B 290.73
CONMED (CNMD) United States $4.013B 45.08
Merit Medical Systems (MMSI) United States $3.925B 33.38
Patterson (PDCO) United States $3.016B 16.21
SmileDirectClub (SDC) United States $2.736B 0.00
Atrion (ATRI) United States $1.150B 37.28
Antares Pharma (ATRS) United States $0.743B 48.89
Retractable Technologies (RVP) United States $0.400B 8.98
Invacare (IVC) United States $0.253B 0.00
Milestone Scientific (MLSS) United States $0.136B 0.00
Lifevantage (LFVN) United States $0.114B 8.29
Pro-Dex (PDEX) United States $0.112B 0.00